Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfer of Metformin into Human Breast Milk and Breastfeeding Child Plasma
2022-501693-19-00Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM), sponsored by Uppsala University. Primary endpoint: Metformin concentration in breastfeeding child plasma at 4 hours after maternal dose. Started Jan 2024; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2022-501693-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501693-19-00.